substance-use-disorders

Documents about substance-use-disorders

• A Novel Blood Test as a Biomarker in Mental Health#884066ClinicalTrials.gov
• Progress report on the regional framework for action to strengthen the public health response to substance use [EM/RC70/INF.DOC.9]#151806WHO IRIS
• An emerging role for synaptic Zn2+ in substance use disorders#184991Dipòsit Digital de la Universitat de Barcelona
• Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment#885230ClinicalTrials.gov
• You "can't get away from the social": Individual, relational, and contextual influences on mental health and substance use-related help-seeking among people in contact with the criminal justice system.#419071PubMed
• Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use#966722ClinicalTrials.gov
• Retinal Thickness in Anxiety, Depression, and Substance Use Disorders: A Systematic Review and Meta-Analysis of Optical Coherence Tomography (OCT) Studies Highlighting Substantial Heterogeneity#29767bioRxiv / medRxiv
• Improving social functioning in people with substance use and mental health disorders using virtual reality (ROPVR): study protocol for a multi-center, pragmatic randomized controlled trial.#186236NCBI PubMed Central
• A fairness framework for natural language processing in substance use disorders and overdose#263318PLOS
• Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders#830127ClinicalTrials.gov
• Phase II Motivational Interviewing: An Experiential Online Training Tool#857045ClinicalTrials.gov
• Clandestine Methamphetamine Drug Manufacturing and Substance Use Disorders in Sri Lanka: A Case study on detection of Clandestine Methamphetamine Laboratory#237865Zenodo (CERN)
• Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones#895831ClinicalTrials.gov
• Comparing two strategies to support the implementation of evidence-based practices for substance use disorders in VA's permanent supportive housing program: a protocol for a type 3 hybrid cluster-randomized controlled trial.#154218NCBI PubMed Central
• Neurobiological Mechanisms of Chess as an Add-On Treatment Against SUD#801854ClinicalTrials.gov
• Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations#811055ClinicalTrials.gov
• Improving Outcomes in Social Services Through Routine Outcome Monitoring and Systematic Client Feedback#901730ClinicalTrials.gov
• Correlates of lifetime blunt/spliff use among cigarette smokers in substance use disorders treatment#609418eScholarship
• Electronic Health Records Are the Next Frontier for the Genetics of Substance Use Disorders#620192eScholarship
• Additional file 1 of Psychosocial outcomes of group-based physical activity among individuals with substance use disorders: a scoping review#337337Figshare
• Correction: Mental Health and ART Adherence in a Multisite International Study: The Mediating Roles of Social Support and Substance Use in People with HIV#634653eScholarship
• Impact of physical activity on sleep in adults recovering from substance use disorders: a protocol for an N-of-1 observational study#405506Figshare
• Medication Treatment for Opioid Use Disorder in Expectant Mothers#908711ClinicalTrials.gov
• Data Sheet 1_Efficacy of intermittent theta-burst stimulation for substance use disorders: a systematic review and meta-analysis of randomized sham-controlled trials.csv#427043Figshare
• An adaptive design to screen, treat, and retain people with opioid use disorders who use methamphetamine in methadone clinics (STAR-OM): study protocol of a clinical trial#683885eScholarship
• Supplementary file 1_GLP-1 receptor agonists and psychiatric outcomes: a bibliometric analysis of research trends, thematic evolution, and collaboration networks.docx#384364Figshare
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study#810371ClinicalTrials.gov
• Lifetime and Twelve-Month Prevalence, Persistence, and Unmet Treatment Needs of Mood, Anxiety, and Substance Use Disorders in African American and U.S. versus Foreign-Born Caribbean Women#609377eScholarship
• Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection#612174eScholarship
• Daily patterns of substance use among young adults who vape nicotine and cannabis: Latent class analysis of smartphone-based daily diary data#642061eScholarship
• Global prevalence and disability burden of brain disorders: Impact of neurological, mental, and substance use disorders / Mohammad Ali Salehinejad, Ali Fathi Jouzdani, Igor D. Bandeira, Stephan Bender, Marom Bikson, Miguel Castelo-Branco, Roi Cohen Kadosh, Floriana Costanzo, Paul E. Croarkin, Pushpal Desarkar, Katherine Dyke, Simon Eickhoff, Paul B. Fitzgerald, Gesa Hartwigsen, Julian Koenig, Davide Martino, Deny Menghini, Fatemeh Sadat Mirfazeli, Vera Moliadze, Michael A. Nitsche, Lindsay M. Oberman, Michael Siniatchkin, Zahra Vaziri, Carmelo M. Vicario, Jaspe Vöckel, Miles Wischnewski, Carsten H. Wolters, Abraham Zangen, Tino Zaehle, Reza Zomorrodi, Andre R. Brunoni#780373Deutsche Nationalbibliothek